Exelixis, Inc. (EXEL)
64.87
-0.96
(-1.46%)
USD |
NASDAQ |
Nov 20, 15:17
Exelixis 30-Day Average Daily Volume : 2.776M for Nov. 19, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| November 19, 2026 | 2.776M |
| November 18, 2026 | 2.774M |
| November 17, 2026 | 2.793M |
| November 16, 2026 | 2.766M |
| November 13, 2026 | 2.763M |
| November 12, 2026 | 2.778M |
| November 11, 2026 | 2.769M |
| November 10, 2026 | 2.797M |
| November 09, 2026 | 2.685M |
| November 06, 2026 | 2.567M |
| November 05, 2026 | 2.567M |
| November 04, 2026 | 2.485M |
| November 03, 2026 | 2.432M |
| November 02, 2026 | 2.366M |
| October 30, 2026 | 2.250M |
| October 29, 2026 | 2.255M |
| October 28, 2026 | 2.220M |
| October 27, 2026 | 2.228M |
| October 26, 2026 | 2.247M |
| October 23, 2026 | 2.249M |
| October 22, 2026 | 2.277M |
| October 21, 2026 | 2.280M |
| October 20, 2026 | 2.289M |
| October 19, 2026 | 2.302M |
| October 16, 2026 | 2.291M |
| Date | Value |
|---|---|
| October 15, 2026 | 2.274M |
| October 14, 2026 | 2.277M |
| October 13, 2026 | 2.265M |
| October 12, 2026 | 2.253M |
| October 09, 2026 | 2.198M |
| October 08, 2026 | 2.159M |
| October 07, 2026 | 2.130M |
| October 06, 2026 | 2.118M |
| October 05, 2026 | 2.131M |
| October 02, 2026 | 2.110M |
| October 01, 2026 | 2.110M |
| September 30, 2026 | 2.147M |
| September 29, 2026 | 2.088M |
| September 28, 2026 | 2.092M |
| September 25, 2026 | 2.128M |
| September 24, 2026 | 2.127M |
| September 23, 2026 | 2.160M |
| September 22, 2026 | 2.181M |
| September 21, 2026 | 2.230M |
| September 18, 2026 | 2.278M |
| September 17, 2026 | 2.284M |
| September 16, 2026 | 2.365M |
| September 15, 2026 | 2.393M |
| September 14, 2026 | 2.470M |
| September 11, 2026 | 2.513M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| BioMarin Pharmaceutical, Inc. | 2.551M |
| Alnylam Pharmaceuticals, Inc. | 2.712M |
| Arrowhead Pharmaceuticals, Inc. | 2.135M |
| Cytokinetics, Inc. | 1.896M |
| Gilead Sciences, Inc. | 6.377M |